Group One Trading’s Werewolf Therapeutics HOWL Stock Holding History

Group One Trading’s Portfolio HOWL Stock Details HOWL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$673	Hold	1,871	–	–	﹤0.01%	7245
2026 Q1	$1.56K	Hold	1,871	–	–	﹤0.01%	7119
2025 Q4	$1.19K	Sell	1,871 -800	-30%	-$973	﹤0.01%	7675
2025 Q3	$5.26K	Buy	+2,671	New	+$3.66K	﹤0.01%	7513
2024 Q1	–	Sell	-100	Closed	-$386	–	7431
2023 Q4	$386	Buy	+100	New	+$255	﹤0.01%	7116
2022 Q4	–	Sell	-15	Closed	–	–	7593
2022 Q3	$0	Hold	15	–	–	﹤0.01%	7802
2022 Q2	$0	Buy	+15	New	+$68	﹤0.01%	8096

Other funds holding HOWL

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return

Verdad Advisers Boston, Massachusetts $104M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Group One Trading's HOWL Position: Q2 2026 in Review

Group One Trading held its Werewolf Therapeutics (HOWL) position steady in Q2 2026 at 1,871 shares worth $673. The position accounts for ﹤0.01% of the portfolio, ranked #7245.

Group One Trading first reported a position in HOWL in Q2 2022 and has held it in 7 quarters since. The position peaked at $5.26K in Q3 2025. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

Group One Trading held 1,871 shares of Werewolf Therapeutics worth $673 as of Q2 2026.
Group One Trading left its Werewolf Therapeutics share count unchanged in Q2 2026.
Werewolf Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7245 holding.
Group One Trading first reported a position in Werewolf Therapeutics in Q2 2022 and has held it in 7 quarters since.
Group One Trading's Werewolf Therapeutics position peaked at $5.26K in Q3 2025.
45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.